Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.48 USD | +1.71% | -1.39% | +24.20% |
Evolution of the average Target Price on Protagonist Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Protagonist Therapeutics, Inc.
JPMorgan Chase | |
Capital One Securities | |
JMP Securities | |
HC Wainwright | |
Piper Sandler | |
SVB Leerink | |
BTIG | |
Northland Securities |
EPS Revisions
- Stock
- Equities
- Stock Protagonist Therapeutics, Inc. - Nasdaq
- Consensus Protagonist Therapeutics, Inc.